Although the HFO mode appeared to be a safe mode with a significant better oxygenation improvement (after the first 24 hours) and fewer crossover rates, it failed to show differences as regards mortality or LOS when compared to the CMV adopting protective lung strategy. In PARDS, HFO had a superior advantage in improving oxygenation, yet with no significant mortality improvement, as multi-organ dysfunction syndrome (MODS) was the most common cause of death in our study and not refractory hypoxemia which is the main problem in PARDS; highlighting that mortality in PARDS is multi-factorial and may not depend only on how fast oxygenation improves.
Acute respiratory distress syndrome (ARDS) is a clinical and physiopathological disorder characterized by acute and diffuse injury to the endothelial and epithelial surfaces of the lung causing a breakdown of gas exchange functions of the lung, resulting in proteinaceous alveolar edema and hypoxemic respiratory failure 1, 2 .
In 1994, a definition was recommended by the American-European Consensus Conference Committee (AECC) 3 . In 2012 the Berlin definition was developed as it showed a better predictive validity for mortality 4 . However, in 2015 the Pediatric Acute Lung Injury Consensus Conference (PALICC) proposed a pediatricspecific definition for acute respiratory distress syndrome which builds on the adult-based Berlin Definition, but has been modified to account for differences between adults and children with acute respiratory distress syndrome, suggesting using this definition for future investigations and clinical care of children with pediatric acute respiratory distress syndrome 5 .
ARDS prevalence varies worldwide, the population-based studies in the United States and Europe, published in 1997 and 2008, indicated that the prevalence of ARDS in adults ranged from 17.9 to 81 per 100,000 person years [6] [7] [8] . Reasons for that large variation may include major differences in demographics and healthcare delivery systems 9 . In pediatrics, the prevalence of ARDS is 2-12.8 per 100,000 person years [10] [11] [12] .
Studies suggested that the overall mortality of ARDS in adults ranges between 27-50% 6, 7, 13, 14 .
Published ARDS attributable mortality in children is lower than in adults (18-27%); however, Australian data suggested that PARDS attributable mortality may be similar to adults (35%) 12, [15] [16] [17] [18] .
Mechanical ventilation is the cornerstone in improving oxygenation 19 but on the other hand, it might also perpetuate lung injury by over-distending and rupturing healthy alveoli and by triggering a secondary inflammatory response that intensifies lung injury from repeatedly opening and collapsing lung units. [20] [21] [22] [23] Lung protective ventilation strategy targets limiting alveolar distension, recruiting nonaerated alveoli, and preventing further alveolar collapse. Conventional mechanical ventilation using low tidal volume combined with adequate positive end expiratory pressure (PEEP) has been shown to reduce mortality 24, 25 .
High frequency oscillation appeared as an alternative technique of ventilation in which extremely small tidal volumes (1-3 ml/kg) are delivered at high frequencies (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) with an oscillatory pump and constant lung recruitment 26 , hence it meets theoretically the goals of a strategy of lung protective ventilation 27 .
Some centers use high frequency oscillation in patients with ARDS who do not tolerate conventional mechanical ventilation [28] [29] [30] , but its use other than as a "rescue" treatment remains controversial 31, 32 .
In a recent systematic review included 10 randomized controlled trials studying the use of HFO versus CMV in moderate and severe ARDS in adult patients, there was no significant difference in hospital or 30-day mortality between both groups 33 .
Researches on pediatric population appear to be insufficient and inconclusive. It is our rationale to study the clinical benefits of HFO compared to CMV in PARDS patients.
In this prospective study, we aimed to compare between the use of HFO and CMV in moderate and severe PARDS patients as defined by AECC as regards oxygenation improvement, mortality, air leaks, ventilation days, length of stay and free mechanical ventilation days.
Material and Methods

Study design
This randomized controlled study was performed in a 9 bedded pediatric intensive care unit (PICU) located in a teaching tertiary care pediatric hospital. We compared the use of HFO versus CMV in PARDS patients as initial modes of ventilation 3 over 5 years (from January 2011 to April 2016). For HFO we used the Fabian High-Frequency Oscillatory Ventilator (Switzerland -Accutronic) ® and for CMV we used the Avea (USA-CareFusion) ® and SERVO-i (Sweden-Maquet) ® ventilators. The Fabian ventilator is fully functional as HFO mode for neonates through pediatrics weighing 30 kilograms. An informed consent was obtained from patients' parents/ legal guardians prior to study entry. This study was approved by the University Ethical Committee (serial number 020687).
The study design was aimed to be parallel. Block randomization was done using Webbased software to assign 200 patients to either HFO or CMV in a 1:1 ratio and sequentially numbered sealed closed envelopes were used by physicians to allocate each patient to either group.
Patients
Two hundred PARDS patients who were undergoing mechanical ventilation were included in the study if they had PaO 2 /FiO 2 ≤ 200 mm Hg or less and bilateral pulmonary infiltrates were visible on chest radiography without evidence of left atrial hypertension, according to AECC definition of ARDS 3 at the start of the study, as the Berlin definition was published at 2012 after the onset of the study 4 . By reviewing the Berlin definition after it first appeared, we found that all of our cases were considered included in the moderate and severe categories of ARDS, and this was our determination throughout our study.
Exclusion criteria were: (1) patients weighing more than 30 kilograms (2) pulmonary edema of cardiac origin or due to volume overload, (3) patients with congenital heart disease, (4) diagnosis of cardiomyopathy or myocarditis, (5) post cardiac surgery for congenital heart defects. Data on demographics, patient diagnosis, mechanical ventilation data, severity of illness, and outcomes were collected. Specific data collected for demographics and severity of illness included age, sex, provisional diagnosis, Pediatric Index of Mortality 2 (PIM2) score, PICU length of stay, mechanical ventilation (MV) days and MV free days.
ARDS was categorized into primary and secondary. Primary causes included pneumonia, aspiration (gastric contents/ barium/ gastrografin), and kerosene toxicity. Secondary causes included severe sepsis and septic shock.
Ventilator protocols
All patients included in our study were allocated to either to HFO group or CMV group once the inclusion criteria were met. Recruitment maneuvers were allowed to be repeated as needed. Optimum lung volumes were defined by chest X-ray if expansion reached 8-9 ribs posteriorly. Initial frequencies were set between 5-12 Hz. I:E ratio was set 1:1 and changed to 1:2 if hyperinflation appeared or to manage hypercarbia. Amplitudes were set to assure tidal volumes 1.5-3 ml/ kg either directly, or by using the volume guarantee option in the HFO device mode, assuring adequate chest wiggling. In Fabian device, bias flow could be set from a range of 5-20 L/min in a 1 lit increment. In our PICU, initial flow was chosen from 8-18 L/min according to weight (wt ˂ 6 kg= 8-12 Lit), (6-15 kg =12-15L), (≥15 kg= ≥15 L).
The main targets were to maintain a stable mean airway pressure in face of spontaneous breaths, if any, and to prevent re-breathing as a cause of hypercarbia through adequate flows in the circuits. The lowest acceptable value was chosen, as if it is inappropriately increased, may increase resistance and increase infants work of breathing. HFO patients were assured for adequate sedation using sedatives (Midazolam with/without Fentanyl or Ketamine), while neuromuscular blocker (Atracurium) was used during LRM and in patients with high flow demands spontaneous breaths. Adequate humidification for the circuits was assured for every case, and closed suctioning technique was used.
Weaning phase
During weaning among cases showed improvement, our primary target was to lower FiO 2 to <0.60 with a target oxygen saturation >90% while achieving optimum lung volumes through keeping mean airway pressure constant, after that, MAP and FiO 2 were allowed to be reduced simultaneously. MAP was reduced in small increments of 1-2 cmH 2 O every 4-6 hours as long oxygenation was maintained, otherwise if adequate oxygenation started to be lost, MAP was restored back to the previous setting. However, in cases of hyper inflated lungs, MAP was immediately decreased in more increments of 3-5 cmH 2 O followed by immediate Chest X-ray to optimize the MAP. Amplitudes were allowed to be lowered if an increase in delivered tidal volumes was observed or when there was excess CO2 wash. When oxygenation was maintained above 95% with MAP of 12-15 cmH 2 O and FiO 2 =0.4 for 6 hours, preparation to transition to CMV was done through assuring adequate spontaneous breathing after stoppage of neuromuscular 
Non-pulmonary treatments for both groups
Parenteral nutrition was started from admission for all patients, targeting 70-75% of mean caloric intake, and trophic feeds were started as soon as shock was resolved or when the general condition becomes stable for 24-48 hours. Net fluid balance was done daily for every case aiming to prevent positive fluid balance while maintaining optimum intravascular volume and accepted urine output. This research is registered in the Cochrane library retrospectively by PACTR201609001779105.
Statistical analysis
All analyses were conducted on an intention to-treat basis. Sample size was estimated based on data from a previous randomized trial 34 . We calculated that a minimum required sample sizes of 36 patients for each group (total 72) will achieve 86% power to detect a difference of 7 between the null hypothesis considering that both groups mean oxygenation index is 18 The level of significance we adopted was p < 0.05. Calculations were performed by the IBM SPSS program version 20.0. Post-hoc achieved power analysis was calculated using GPower version 3.1.9.2, and it was done on 2 steps; the first analyzed the sum of both groups (200 patients) and showed a power of 1, the second step analyzed each treatment group separately and showed a power of 0.99 for each of CMV and HFO groups.
Results
Comparison between the baseline data and outcomes of both groups
Both groups were comparable for age, height, weight and PIM 2 scores (Table I Table VII .
Outcomes
30-day mortality
It did not differ between the CMV and the HFO groups (43% and 45% respectively, p= 0.776). Kaplan-Meier survival curves did not show significant differences between both groups (p= 0.787; Fig.1 ).
Air leaks
Air leak syndromes incidence did not differ significantly between both groups (p= 0.631). 
Oxygenation improvement
Oxygenation index
Although the median OI after 24 hours of enrollment was lower in the HFO group, it did not reach a statistical difference (p =0.94), but the median OI decrease percent, calculated as (baseline OI-OI after 24 hours)*100/ baseline OI), was significantly higher among the HFO group (41.9%, 27.4%, respectively, p= 0.004; Fig.2b ) as the baseline median OI was significantly higher among the HFO group (p=0.005).
Causes of death
MODS was the most common cause of death (81.8% of all deaths), while refractory hypoxemia was the cause in only 6.8% of deaths (Table II) . In kidney failure group, we specified cases with acute renal injury who needed peritoneal dialysis and death was their fate. (Table III) . Air leak syndromes showed non adjusted odds ratio (OR) for mortality of 8.074 (95% CI 2.27-28.7). There was no significant difference in mortality regarding ARDS category whether primary or secondary (p=0.63).
Comparison between survivors and non-survivors groups
Outcomes among survivors of both groups
Oxygenation improvement
Results showed a comparable PIM 2 score and baseline PaO 2 /FiO 2 (p=0.67, p=0.3 respectively). While OI after 24 hours did not differ significantly between both groups, the baseline OI among the HFO group was significantly higher and OI decrease percent was higher among HFO group (p=0.59, p= 0.001, p<0.001 respectively). Also the HFO group showed higher median PaO 2 /FiO 2 after 24 hours and higher median PaO 2 /FiO 2 increase percent (p<0.001, p<0.001 respectively) ( Table  IV) .
Length of stay and ventilation days
Both the CMV and HFO groups did not show statistical differences as regards PICU length of stay (p=0.28), mechanical ventilation (MV) days (p=0.65), MV free days till 30 days (p= 0.65) and MV free days in PICU (p=0.57) (Table IV) .
Midazolam and Atracurium intake
The HFO group had a significantly higher percent of patients received Atracurium and significantly higher Midazolam infusion dosages (p<0.001, p<0.001 respectively) (Table IV) .
Receiver operating characteristic (ROC) curves and mortality discrimination
The baseline OI and OI after 24 hours were statistically significant discriminators of occurrence of mortality with areas under the receiver operating characteristic (AUROC) curve = 0.68 and 0.79 respectively (Fig. 3 , Table V ). Pair wise comparison showed that the OI after 24 hours was more significant discriminator for mortality than baseline OI (p<0.001; cutoff values of >8.5 versus >16.6, respectively).
The baseline PaO 2 /FiO 2 and PaO 2 /FiO 2 after 24 hours were statistically significant discriminators of occurrence of mortality with AUROC curve = 0.62and 0.76 respectively (Fig.  4 , Table V ). Pair wise comparison showed that PaO 2 /FiO 2 after 24 hours was more significant discriminator for mortality when compared to baseline PaO 2 /FiO 2 (p<0.001; cutoff values of ≤139 versus ≤114, respectively).
Relation between mortality and OI grades
The results showed that the mortality increased as the baseline OI increased (p <0.001) and also as OI after 24 hours increased (p <0.001; Fig. 5 ).
There was a higher incidence of survivors in the HFO group with baseline OI >16 than the corresponding CMV group (40% versus 15.8%, p=0.004) (Table VI) .
Discussion
The present study aimed at evaluating early application of HFO compared to CMV on the PARDS patients once the patients met the inclusion criteria. We randomly allocated 200 PARDS patients in 1:1 ratio to HFO and CMV modes. Mortality rates among CMV and HFO didn't show significant differences. Kaplan-Meier survival curve did not show statistical differences. The present results matched previous studies results including one pediatric RCT 35 and some adult studies as well including 2 meta analyses 34, [36] [37] [38] , while other studies stated improved mortality among HFO group, their results were not statistically significant 36, 39 . In a review by Kneyber et al. 40 in 2012 about published clinical experiences about HFO in pediatrics, it was concluded that a beneficial role of HFO on mortality is not established; yet it proposed a question about the optimum timing and settings of HFO has been employed.
On the other hand, a retrospective observational study concluded that application of early HFO was associated with worse outcomes and higher mortality among pediatrics with acute hypoxemic respiratory failure 41 ; however, that study was retrospective lacking randomization and missing data on certain key variables as PaO 2 , FiO 2 , PaO 2 /FiO 2 , presence or absence of air leaks and causes of death.
In the present study, MODS was the most common cause of death among both groups (81.4% in CMV, 82.2% in HFO) followed by a small percent with refractory hypoxemia (2.3% in CMV, 11.1% in HFO). Several studies in adults showed similar results; a study by Stapleton et al. 42 (consecutive cohorts analysis) found that MODS was the most common cause of death (30 to 50%), while hypoxemic respiratory failure caused a small percentage (13 to 19%) of deaths. Also, MODS was the most common single cause (50%) in a study 
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by Bersten et al. 43 A RCT by Derdak et al. 36 stated a similar finding but with incidences of (50% in CMV and 56% in HFO) for MODS as a cause of death 36 .
As regards pediatrics, two prospective studies showed that MODS was the most frequent cause of death among ALI/ARDS pediatric patients with an incidence of 51% 11 and 93% 15 . So it appears that MODS is the commonest cause of death and not refractory hypoxemia; which is the main problem in ARDS.
These data may partially explain why mortality rates did not differ significantly in the present study although the apparent advantage of HFO in improving oxygenation over the first 24 hours, as mortality appears to be multifactorial and may not depend only on how fast oxygenation improves. A research suggests that repetitive overstretching or collapse of lung units with every respiratory cycle can generate local and systemic inflammation, contributing to multi-organ dysfunction and leading to death 44 . This explains the relationship between ventilator induced lung injury (VILI) and initiating or augmenting MODS, hence the importance of preventing VILI in every PARDS case.
As regards oxygenation improvement, we found that HFO significantly improved oxygenation after 24 hours of enrollment, a finding that is comparable with results in several pediatric studies 35, [45] [46] [47] and adult studies 34, 36 . Also survivors among HFO group showed significant higher OI decrease percent, PaO 2 /FiO 2 after 24 hours and higher PaO 2 /FiO 2 increase percent.
Although that apparent advantage of HFO in improving oxygenation, survivors of both groups did not show differences in regards to PICU LOS or MV days coinciding with one pediatric RCT 35 , one adult RCT 34 and two recent trials in 2013 (OSCAR and OSCILLATE trials) 37, 38 which revealed no statistical differences as regards the total duration of ICU stay or the total hospital stay. Possible explanations in the present study may include; the increased use of neuromuscular blockers (NMBs) in addition to significantly higher doses of sedatives (midazolam) among HFO groups, in addition to the use of CMV mode during weaning from the HFO mode instead of direct extubation to nasal cannulae or mask. Arroliga et al. 48 found NMBs use is associated with longer duration of mechanical ventilation, weaning time, stay in the ICU, and higher mortality. Kress et al. 49 showed in a RCT that continuous sedation had a significantly longer stay in the ICU and a significantly longer duration of mechanical ventilation. As HFO is associated with more usage of NMBs and continuous sedation, we expect that an earlier trial of transition from the HFO mode to the CMV mode as soon as possible as OI improves could be an optimal timing for reduction in NMBs and sedation dosages; hence MV days and total ICU stay may shorten.
The HFO group showed lower air leaks occurrence (8% versus 11%), but without statistical significance. Several studies showed no statistical differences in air leaks frequencies between both modes [34] [35] [36] 50 . A meta-analysis 38 showed higher rate of new onset barotraumas among HFO group, but did not reach statistical difference after all. HFO use seems from a theoretical point of view to be the safest ventilatory mode as it delivers tidal volumes no more than the dead space with constant mean airway pressure to prevent atelectasis 51 . On the other hand the CMV protective lung strategy as stated by the Acute Respiratory Distress Syndrome Network 24 limiting tidal volumes and peak pressures with adequate positive end expiratory pressures (PEEP) seems to be working well. In the present study air leaks were significantly higher among nonsurvivors group.
Sixteen cases (16%) of CMV crossed over to HFO treatment after allocation, while no cross over occurred among HFO group. The causes included persistent air leaks (2 cases) and oxygenation failure despite good lung volumes (14 cases), while in an adult RCT by Bollen et al. 34 there was no statistical differences in cross over among both groups.
As regards the survivors and nonsurvivors, there were no differences as regards gender, weight, height or age. PIM 2 scores on admission were significantly higher among nonsurvivors group as well as baseline OI and after 24 hours OI, while the survivors group had significantly higher values of baseline PaO 2 /FiO 2 , PaO 2 /FiO 2 after 24 hours, PaO 2 / FiO 2 increase percent and OI decrease percent.
The OI trend was found to predict mortality in several studies 35, 36, 52 . One of them is a pediatric RCT by Arnold et al. 35 found that OI was significantly lower among survivors during first 72 hours. Other several pediatric investigators have demonstrated stronger associations between OI and mortality for each day the patient remains on mechanical ventilation 53, 54 . Data from two pediatric studies 11, 55 suggested that OI may have better discriminatory value for mortality than PaO 2 / FiO 2 , and the relationship between OI and mortality strengthens as the patient remains on mechanical ventilation for the first 3 days 55 .
So it was recommended that OI, in preference to PaO 2 /FiO 2 , should be the primary metric of lung disease severity to define PARDS 5 .
In the present study, we found a significant increase in mortality rates as the baseline OI and OI after 24 hours increased. Khemani et al. 5 reviewed seven PARDS studies 10, 11, 15, 18, 53, 56, 57 and found stepwise increases in mortality as the OI severity increases between OI groups (4-8 group, 8-16 group and >16 group).
We discriminated mortality using baseline and 2 nd day values of OI and PaO 2 /FiO 2 . The OI after 24 hours and PaO 2 /FiO 2 after 24 hours were statistically significant discriminators for mortality when compared to baseline OI and baseline PaO 2 /FiO 2 respectively.Cutoff value for OI after 24 hours was >8.5 and for PaO 2 / FiO 2 after 24 hours was ≤ 139.In the present study, no case with OI after 24 hours>16 survived.
The present study showed that there was a higher incidence of survivors in HFO group with baseline OI>16 in accordance with observational studies that showed that better survival rates in more severe ARDS with higher OI occurred with HFO treatment 28, 34, 52 . Also, HFO has been recommended for patients who require high mean airway pressure and FiO 2 exceeding 60% corresponding to an OI > 20 when PaO 2 =60 mmHg 58 .
Although the HFO group showed a significant improved oxygenation when compared to the CMV group after 24 hours of enrollment, there were no significant differences as regards 30-day mortality, LOS or MV days. Mortality appears to be multi-factorial and may not depend only on how fast oxygenation improves. We assume that increased NMBs use and higher sedation dosages among HFO group might have prolonged their LOS and increased their MV days. We propose that an earlier trial of transition from the HFO mode to the CMV mode as soon as OI improves may be an attempt to reduce LOS among HFO treated patients; highlighting that both modes may have a cooperative role rather than a competitive role. This could be a subject for further studies.
The HFO mode appears to be a safe mode in PARDS with significantly lower rates of crossover and with a better chance of survival in patients with baseline OI > 16. The limitation of this study is that it is a single center study and more studies about the hemodynamic parameters during mechanical ventilation are needed.
